ArticleArchives of microbiology2022
In silico prediction of putative antimicrobial targets in Xanthomonas citri pv. punicae using genome subtraction approach.
Article in Archives of microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Xanthomonas citri pv. punicae (Xcp) is the causative agent of bacterial blight disease in pomegranate and severely affects its production. The current control strategies for this disease provide inadequate protection. Identifying novel bactericide target proteins in pathogenic bacteria and formulating selective chemicals against those proteins is an effective approach to containing the disease. In this study, we used the genome subtraction approach and identified 595 Xcp proteins that are non-homologous to the pomegranate proteome, of which 69 are found to be essential proteins. These 69 proteins are considered possible drug target proteins in Xcp. Further, these proteins were subjected to subcellular localization, KEGG pathway, and virulent prediction analysis. Our systematic bioinformatics analysis deciphered 33 virulent proteins, of which two are iron complex outer membrane receptors, and the third is a T4SS PilQ protein localized in the outer membrane. These outer membrane-localized proteins are potential candidate targets for antibacterial agents, and the two iron complex outer membrane receptor proteins show homology with the Drug bank listed drug target sequences. From this study, we inferred that PilQ could be considered a novel antimicrobial target of Xcp, and therefore we deciphered the PilQ protein-protein interacting partners and phylogenetic relatedness. We have also predicted the physiochemical properties, secondary, and tertiary structure of PilQ protein which will be helpful in the design of antimicrobials. The identification of Xcp specific targets is the first step towards the development of a chemical control agent that is more selective with minimum environmental impact.
Indexed as
Identifiers
35838834What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.